ArticleScientific reports2021

Contribution of p53 in sensitivity to EGFR tyrosine kinase inhibitors in non-small cell lung cancer.

Sangyong Jung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.